Desilets, A., Blanc-Durand, F., Lau, S., Hakozaki, T., Kitadai, R., Malo, J., Belkaid, W., Richard, C., Messaoudene, M., Cvetkovic, L., Kazandjian, S., Tehfe, M., Florescu, M., Jao, K., Daaboul, N., Owen, S., Shieh, B., Agulnik, J., Cohen, V., Charbonneau, C., Marcoux, N., Blais, N., Leighl, N. B., Bradbury, P. A., Liu, G., Shepherd, F. A., Bahig, H., Routy, B., Sacher, A., & Elkrief, A. (2021). durvalumab therapy following chemoradiation compared with a historical cohort treated with chemoradiation alone in patients with stage III non–small cell lung cancer: A real-world multicentre study. European journal of cancer, 142, 83–91. http://access.bl.uk/ark:/81055/vdc_100117394158.0x00001f